U.S. Pharmacist Weekly News

July 31, 2024

Older Adults Discontinue Medication for Some Conditions

Older patients often tell pharmacists that they take too many drugs and wish they could discontinue some of them. But those comments should be viewed with some caution, according to a recent study finding that drugs dealing with symptomless risk factors are often the most unpopular. Find out why the authors recommend a comprehensive medication review in those cases.

Study: Pharmacist Prescribing of OACs Reduced AF Stroke Risk

A Canadian study makes a strong argument for pharmacists to play a larger role in making sure that atrial fibrillation (AF) is adequately treated to reduce patients’ risk of stroke. A trial in the Alberta Province showed that pharmacist involvement in oral anticoagulants (OACs) made a significant difference for AF patients in 27 community pharmacies. Read more.

Concomitant CYP2D6-Metabolized Opioids, Antidepressants Questioned

The concomitant use of cytochrome P450 2D6 (CYP2D6)–metabolized opioids and antidepressants is common among older nursing home residents. A new study strongly warns against it, however, noting that the practice leads to worsening pain, opioid-use disorder, and more emergency department visits and hospitalizations. Learn more about the results of this study.

Exploring Insulin, Noninsulin Antidiabetics and Lung Cancer Risk

Some recent studies have suggested a potential connection between insulin therapy and an increased incidence of lung cancer. In response, researchers sought to determine which noninsulin antidiabetic drugs might be better choices in terms of avoiding heightened lung cancer risk. Find out which medications appear to be the best options.